Recent news on Tolbutamide

Insulin (in)dependent  -  May 23, 2007
South Bend Tribune,Avery now takes a medicine called tolbutamide instead of shots of insulin. She was gradually weaned off the injections and on to the tablets over a period

All about Oral Anti-Diabetic Drugs  -  May 8, 2007
Newindpress (subscription),Types ¦ Sulphonylureas Examples of such drugs are tolbutamide, glibenclamide and glipizide. ¦ Biguanides Examples of such drugs are phenformin and metformin

Ciclopirox 8% Nail Lacquer Topical Solution for the Treatment of ...  -  May 16, 2007
Journal of the American Podiatric Medical Association (subscription)GUMBLETON M, HOUSTON WA, NICHOLLS PJ, ET AL: Tolbutamide pharmacokinetics, in the presence of itraconazole, in the rat. J Pharm Pharmacol 39 (suppl 1): 150,

Greater LDL Cholesterol Reduction with VYTORIN Compared to Lipitor ...  -  Dec 21, 2006
Business Wire (press release),Cytochrome P450: Ezetimibe had no significant effect on a series of probe drugs (caffeine, dextromethorphan, tolbutamide, and IV midazolam) known to be

Greater LDL Cholesterol Reduction with VYTORIN Compared to Lipitor ...  -  Dec 21, 2006
Business Wire (press release),Cytochrome P450: Ezetimibe had no significant effect on a series of probe drugs (caffeine, dextromethorphan, tolbutamide, and IV midazolam) known to be ...

Widely Used Diabetes Drug May Not Work  Oct 20, 2006
...in people taking pioglitazone in combination with another class of drugs called sulfonylureas, which include medications such as tolbutamide, glipizide and ... -CBC News, Diabetes Drug Benefits vs. Risks  Oct 21, 2006
The researchers also concluded that taking pioglitazone in combination with the sulfonylureas such as tolbutamide, glipizide and glimepiride may cause ... -MedIndia, FDA Approves Once-Daily JANUVIA(TM), the First and Only DPP-4 ...  Oct 17, 2006
Clinically meaningful interactions would not be expected with other sulfonylureas (eg, glipizide, tolbutamide, and glimepiride) which, like glyburide, are ... -Genetic Engineering News (press release), Drug Restores Insulin Secretion for Rare Type 1 Cases  Aug 3, 2006
...glycemic control in 49 patients with Kir6.2 mutations who were given oral sulfonylureas, either glyburide, glipazide, gliclazide, tolbutamide, or glimerpiride. ... -MedPage Today

Switching from Insulin to Oral Sulfonylureas in Patients with ...  Aug 2, 2006
...meal, and glucagon. The response of mutant K ATP channels to the sulfonylurea tolbutamide was assayed in xenopus oocytes. Results A ... -New England Journal of Medicine (subscription)

Actions of GLP-1 on k atp channel-dependent and -independent ...  Jun 29, 2006
GLP-1 similarly augmented the K ATP channel-independent insulin-releasing effects of tolbutamide, glibenclamide or nateglinide. ... -Journal of Endocrinology



Cell specificity of the cytoplasmic Ca 2+ response to tolbutamide ...  May 10, 2006
We now used tolbutamide and arginine to test if the cell specificity exists also for the response to non-nutrient stimulation of b-cells and if so, whether it ... - Journal of Endocrinology

Shin Nippon Biomedical Laboratories Obtains New Knowledge on Drug ...  May 8, 2006
...and Experimental Therapeutics, under the title "CYP2C76, a novel CYP in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone ... - Japan Corporate News





FASEB: Herbal Remedies Alter Drug Effects  Apr 5, 2006
Echinacea purpurea) on metabolic enzyme activity using the cytochrome P450 probe drugs caffeine (CYP1A2), Orinase (tolbutamide, CYP2C9), dextromethorphan ... - MedPage Today

Data Analysis Showed VYTORIN(R) (Ezetimibe/Simvastatin) ...  Mar 13, 2006
Cytochrome P450: Ezetimibe had no significant effect on a series of probe drugs (caffeine, dextromethorphan, tolbutamide, and IV midazolam) known to be ... - International News Service



Detrimental actions of metabolic syndrome risk factor ...  Feb 2, 2006
...including nutrients (alanine, arginine, 2- ketoisocaproate), hormones (GLP-1, GIP and CCK-8), neurotransmitter (carbachol), drug (tolbutamide) as well as a ... - Journal of Endocrinology

FDA Approves EMEND(R) (aprepitant), in Combination with Other ...  Jan 11, 2006
CONTRAINDICATIONS). Aprepitant has been shown to induce the metabolism of S(-) warfarin and tolbutamide, which are metabolized through CYP2C9. ... - Business Wire

Sulfonylureas for Type 2 Diabetes Drugs Linked to Heart Deaths  Jan 17, 2006
1970. This study found a higher rate of cardiovascular death in patients taking Orinase (tolbutamide) compared with placebo. However ... - CNN

Risks of sulfonylurea drugs in the treatment of diabetes mellitus  Jan 16, 2006
Patients who were prescribed a sulfonylurea drug (chlorpropamide, tolbutamide or glyburide) experienced higher mortality rates than those who received metformin ... - EurekAlert

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional